Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v11-FR | Version v2-FR | |
---|---|---|
Language | French | French |
Date Updated | 2018-02-01 | 2017-11-13 |
Drug Identification Number | 02267659 | 02267659 |
Brand name | ADENOSINE INJECTION | ADENOSINE INJECTION |
Common or Proper name | Adenosine Injection | Adenosine Injection |
Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
Ingredients | ADENOSINE | ADENOSINE |
Strength(s) | 3MG | 3MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVENOUS | INTRAVENOUS |
Packaging size | 3mg/mL 2mL | 3mg/mL 2mL |
ATC code | C01EB | C01EB |
ATC description | OTHER CARDIAC PREPARATIONS | OTHER CARDIAC PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
Anticipated start date | ||
Actual start date | 2017-11-10 | 2017-11-10 |
Estimated end date | 2018-01-05 | Unknown |
Actual end date | 2017-12-21 | |
Shortage status | Resolved | Actual shortage |
Tier 3 Status | No | No |
Company comments | Product on backorder, code K051002 Adenosine 3mg/mL 2mL Prefilled Syringe available for substitution. | Product on 50% allocation, code K051002 Adenosine 3mg/mL 2mL Prefilled Syringe available for substitution. |
Health Canada comments |